Chronic kidney disease with persistent non-visible haematuria — MSRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Arrange a renal ultrasound scan
He has chronic kidney disease: eGFR is below 60 mL/min/1.73 m² on measurements separated by more than 3 months, and he has confirmed albuminuria. He also has persistent invisible haematuria, established by at least 2 positive reagent-strip tests out of 3. NICE recommends renal ultrasound for all adults with CKD who have visible or persistent invisible haematuria. Therefore, renal ultrasound is the appropriate next investigation. Annual surveillance alone is recommended for persistent invisible haematuria in the absence of proteinuria; this patient has confirmed albuminuria and CKD. A suspected cancer pathway referral for bladder cancer is not indicated: non-visible haematuria requires age 60 years or over plus dysuria or a raised white cell count, neither of which is present. Routine nephrology referral is not required solely for ACR 14–16 mg/mmol with stable G3a CKD; the relevant referral threshold is ACR above 30 mg/mmol together with haematuria. Non-contrast CT KUB would be appropriate when stone disease is clinically suspected, but he has no colic or other features suggesting calculi.
Reference: NICE NG203: Chronic kidney disease: assessment and management — Haematuria and indications for renal ultrasound (2021) — https://www.nice.org.uk/guidance/ng203/chapter/Recommendations NICE NG203: Chronic kidney disease: assessment and management — Referral criteria (2021) — https://www.nice.org.uk/guidance/ng203/chapter/Recommendations NICE NG12: Suspected cancer: recognition and referral — Bladder cancer recommendation 1.6.4 (2015) — https://www.nice.org.uk/guidance/ng12/chapter/recommendations-organised-by-site-of-cancer